Research Into Etanercept Cytokine Antagonism in Ventricular Dysfunction - RENEWAL - RECOVER

Description:

The goal of the Research Into Etanercept Cytokine Antagonism in Ventricular Dysfunction (RECOVER) trial was to evaluate the efficacy of etanercept, a recombinant human tumor necrosis factor (TNF) receptor, compared with placebo among patients with chronic heart failure (CHF) and a left ventricular ejection fraction (LVEF) ≤30%.